ACB
ACB
NASDAQ · Pharmaceuticals

Aurora Cannabis Inc

$3.26
-0.12 (-3.55%)
As of Mar 22, 10:31 PM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 6 60%
Hold 4 40%
Sell 0 0%
Price Target
Analyst Price Target +520.2% upside
Low Target $15.45
Average Target $20.22
High Target $24.58
Current Price $3.26
Current
$3.26
Target
$20.22
$15.45 $20.22 avg $24.58
Scenario Analysis
Bear Case
$15.45
373.9%
Low target
Base Case
$20.22
+520.2%
Avg target
Bull Case
$24.58
+654.0%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$9.33
-65.1% from high
52-Week Low
$4.50
+-27.6% from low
Target vs 52W High
$20.22
+116.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%